Continuum of

Progress

A main actor in pharmaceutical synthesis and specialty ingredients

A leader in pharmaceutical synthesis

Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.

Discover

A cross-functional knowledge in specialty ingredients

Seqens offers a wide continuum of technologies covering small-scale to large-scale chemical synthesis and distillation including distinctive reactions such as Fiedel-Craft, Grignard and low-metal capabilities. This industrial network is supported by focused R&D capabilities. Seqens offers high purity oxygenated solvents leveraging its back-integrationl and a large range of Minerals Specialties produced.

Discover

A large expertise
in cosmetics

Seqens has built a wide, comprehensive and cutting edge offer for the cosmetic market sourced in pharmaceutics and fine chemistry know-hows.

Discover

A continuum of technologies

Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia.

More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.

Newsroom

#Live

Products & Technologies

Bicarbonate sodium used in dialysis

Interview of Elsa Prous, Market Manager and Global Key Account Manager & Sophie Mouzon, Development Quality & Customer Assistance Manager of…
General

New kid on the block

THE PAST FEW YEARS have seen the rise of a major player in pharmaceutical CDMO services in Seqens. The name is pronounced like…
General

New England CRO/CMO Council to Hold Town Hall Meeting and Discussion

Kernwood Country Club, Monday, October 26, 2015, 6pm-8:30pm The New England CRO/CMO Council, a non-profit trade organization made up of contract research…

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries